Booz Allen Hamilton Holding Corp (BAH) stock
Close on Oct 30, 2026Market cap $10.64BP/E 13.9Yield 2.53%
Earnings
Booz Allen Hamilton's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Booz Allen Hamilton's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Dec 31, 2026 | Jan 22, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Sep 30, 2026 | Oct 23, 2026before the open | $2.80B | -3.4% | $1.50 | $1.76 | Release |
| Q1 FY2027ended Jun 30, 2026 | Jul 24, 2026before the open | $2.80B | -3.4% | $1.63 | $1.81 | Release |
| Q4 FY2026ended Mar 31, 2026 | May 22, 2026before the open | $2.80B | -6.7% | $1.68 | $1.78 | Release |
| Q3 FY2026ended Dec 31, 2025 | Jan 23, 2026before the open | $2.60B | -11.0% | $1.63 | $1.77 | Release |
| Q2 FY2026ended Sep 30, 2025 | Oct 24, 2025before the open | $2.90B | -7.8% | $1.42 | $1.49 | Release |
| Q1 FY2026ended Jun 30, 2025 | Jul 25, 2025before the open | $2.90B | 0.0% | $2.16 | $1.48 | Release |
| Q4 FY2025ended Mar 31, 2025 | May 23, 2025before the open | $3.00B | +8.3% | – | $1.61 | Release |
| Q3 FY2025ended Dec 31, 2024 | Jan 31, 2025before the open | $2.92B | +13.6% | $1.45 | $1.55 | Release |
| Q2 FY2025ended Sep 30, 2024 | Oct 25, 2024before the open | $3.15B | +17.8% | $3.01 | $1.81 | Release |
| Q1 FY2025ended Jun 30, 2024 | Jul 26, 2024before the open | $2.90B | +9.2% | $1.27 | $1.38 | Release |
| Q4 FY2024ended Mar 31, 2024 | May 24, 2024before the open | $2.77B | +14.0% | $0.98 | $1.33 | Release |
| Q3 FY2024ended Dec 31, 2023 | Jan 26, 2024before the open | $2.57B | +12.7% | $1.11 | $1.41 | Release |
| Q2 FY2024ended Sep 30, 2023 | Oct 27, 2023before the open | $2.67B | +16.1% | $1.29 | $1.29 | Release |
| Q1 FY2024ended Jun 30, 2023 | Jul 28, 2023before the open | $2.65B | +18.0% | $1.22 | $1.47 | Release |
| Q4 FY2023ended Mar 31, 2023 | May 26, 2023before the open | $2.43B | +8.5% | -$0.52 | $1.01 | Release |
| Q3 FY2023ended Dec 31, 2022 | Jan 27, 2023before the open | $2.28B | +12.3% | $0.23 | $1.07 | Release |
| Q2 FY2023ended Sep 30, 2022 | Oct 28, 2022before the open | $2.30B | +9.0% | $1.28 | $1.34 | Release |
| Q1 FY2023ended Jun 30, 2022 | Jul 29, 2022before the open | $2.25B | – | $1.03 | $1.13 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 20, 2022before the open | $2.24B | – | $0.68 | $0.86 | Release |
| Q3 FY2022ended Dec 31, 2021 | Jan 28, 2022before the open | $2.03B | – | $0.95 | $1.02 | Release |
| Q2 FY2022ended Sep 30, 2021 | Oct 29, 2021before the open | $2.11B | – | $1.14 | $1.26 | Release |
| Q1 FY2022ended Jun 30, 2021 | Jul 30, 2021before the open | – | – | – | – | Release |
| Q4 FY2021ended Mar 31, 2021 | May 21, 2021before the open | – | – | – | – | Release |
| Q3 FY2021ended Dec 31, 2020 | Jan 29, 2021before the open | – | – | – | – | Release |
| Q2 FY2021ended Sep 30, 2020 | Oct 30, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Booz Allen Hamilton's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenueGAAP | FY2027 | $11.30B – $11.60B | – | New | Oct 23, 2026 |
| Revenue | FY2027 | $11.20B – $11.70B | $11.20B – $11.70B | Reaffirmed | Jul 24, 2026 |
| Revenue GrowthGAAP | FY2027 | +1% – +3% | – | New | Oct 23, 2026 |
| Revenue Growth | FY2027 | 0% – +4% | 0% – +4% | Reaffirmed | Jul 24, 2026 |
| Adjusted EBITDA Margin on Revenuenon-GAAP | FY2027 | 11% | – | New | May 22, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $1.26B – $1.29B | – | New | Oct 23, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $1.24B – $1.29B | $1.24B – $1.29B | Reaffirmed | Jul 24, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $6.50 – $6.70 | – | New | Oct 23, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2027 | $6.00 – $6.35 | $6.00 – $6.35 | Reaffirmed | Jul 24, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $850.00M – $925.00M | – | New | Oct 23, 2026 |
| Free Cash Flownon-GAAP | FY2027 | $825.00M – $925.00M | $825.00M – $925.00M | Reaffirmed | Jul 24, 2026 |
| Adjusted EBITDA Margin on Revenuenon-GAAP | FY2027 | 11% | – | New | Oct 23, 2026 |
| Adjusted EBITDA Margin on Revenuenon-GAAP | FY2027 | 11% | – | New | Jul 24, 2026 |
Guidance vs results
The last range Booz Allen Hamilton gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adjusted Diluted EPS | $5.95 – $6.15 | $6.52Σ4Q | Above range |
| FY2026 | Revenue | $11.30B – $11.40B | $11.20BΣ4Q | Below range |
| FY2026 | Revenue growth | -6% – -5% | -6.4%Σ4Q | Below range |
| FY2025 | Adjusted Diluted EPS | $6.25 – $6.40 | $6.35Σ4Q | Within range |
| FY2025 | Revenue growth | +12% – +13% | +12.21%Σ4Q | Within range |
Guidance history
Every forecast Booz Allen Hamilton put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 23, 2026 | Adjusted EBITDA | FY2027 | $1.26B – $1.29B | New |
| Oct 23, 2026 | Adjusted Diluted EPS | FY2027 | $6.50 – $6.70 | New |
| Oct 23, 2026 | Free Cash Flow | FY2027 | $850.00M – $925.00M | New |
| Oct 23, 2026 | Adjusted EBITDA Margin on Revenue | FY2027 | 11% | New |
| Oct 23, 2026 | Revenue Growth | FY2027 | +1% – +3% | New |
| Oct 23, 2026 | Revenue | FY2027 | $11.30B – $11.60B | New |
| Jul 24, 2026 | Adjusted EBITDA | FY2027 | $1.24B – $1.29B | Reaffirmed |
| Jul 24, 2026 | Adjusted Diluted EPS | FY2027 | $6.00 – $6.35 | Reaffirmed |
| Jul 24, 2026 | Free Cash Flow | FY2027 | $825.00M – $925.00M | Reaffirmed |
| Jul 24, 2026 | Adjusted EBITDA Margin on Revenue | FY2027 | 11% | New |
| Jul 24, 2026 | Revenue Growth | FY2027 | 0% – +4% | Reaffirmed |
| Jul 24, 2026 | Revenue | FY2027 | $11.20B – $11.70B | Reaffirmed |
| May 22, 2026 | Adjusted EBITDA | FY2027 | $1.24B – $1.29B | New |
| May 22, 2026 | Adjusted Diluted EPS | FY2027 | $6.00 – $6.35 | New |
| May 22, 2026 | Free Cash Flow | FY2027 | $825.00M – $925.00M | New |
| May 22, 2026 | Adjusted EBITDA Margin on Revenue | FY2027 | 11% | New |
| May 22, 2026 | Revenue | FY2027 | $11.20B – $11.70B | New |
| May 22, 2026 | Revenue Growth | FY2027 | 0% – +4% | New |
| Jan 23, 2026 | Adjusted EBITDA | FY2026 | $1.20B – $1.22B | Narrowed |
| Jan 23, 2026 | Adjusted Diluted EPS | FY2026 | $5.95 – $6.15 | Raised |
| Jan 23, 2026 | Free Cash Flow | FY2026 | $825.00M – $900.00M | Lowered |
| Jan 23, 2026 | Revenue Growth | FY2026 | -6% – -5% | Lowered |
| Jan 23, 2026 | Revenue | FY2026 | $11.30B – $11.40B | Lowered |
| Oct 24, 2025 | capital expenditures | FY2026 | $100.00M | New |
| Oct 24, 2025 | Adjusted EBITDA | FY2026 | $1.19B – $1.22B | Lowered |
| Oct 24, 2025 | Adjusted Diluted EPS3 | FY2026 | $5.45 – $5.65 | Lowered |
| Oct 24, 2025 | Free Cash Flow4 | FY2026 | $850.00M – $950.00M | Lowered |
| Oct 24, 2025 | Revenue Growth | FY2026 | +4% – +6% | Raised |
| Oct 24, 2025 | Revenue | FY2026 | $11.30B – $11.50B | Lowered |
| Jul 25, 2025 | Adjusted EBITDA | FY2026 | $1.32B – $1.37B | Reaffirmed |
| Jul 25, 2025 | Adjusted Diluted EPS3 | FY2026 | $6.20 – $6.55 | Reaffirmed |
| Jul 25, 2025 | Free Cash Flow4 | FY2026 | $900.00M – $1.00B | Raised |
| Jul 25, 2025 | Adjusted EBITDA Margin on Revenue | FY2026 | 11% | New |
| Jul 25, 2025 | Revenue Growth | FY2026 | 0% – +4% | New |
| Jul 25, 2025 | Revenue | FY2026 | $12.00B – $12.50B | Reaffirmed |
| May 23, 2025 | Adjusted EBITDA | FY2026 | $1.32B – $1.37B | New |
| May 23, 2025 | Adjusted Diluted EPS | FY2026 | $6.20 – $6.55 | New |
| May 23, 2025 | Free Cash Flow | FY2026 | $700.00M – $800.00M | New |
| May 23, 2025 | Adjusted EBITDA Margin on Revenue | FY2026 | 11% | New |
| May 23, 2025 | Revenue Growth | FY2026 | 0% – +4% | New |
| May 23, 2025 | Revenue | FY2026 | $12.00B – $12.50B | New |
| Jan 31, 2025 | Adjusted EBITDA | FY2025 | $1.31B – $1.33B | New |
| Jan 31, 2025 | Adjusted Diluted EPS | FY2025 | $6.25 – $6.40 | New |
| Jan 31, 2025 | Free Cash Flow | FY2025 | $850.00M – $925.00M | New |
| Jan 31, 2025 | Adjusted EBITDA Margin on Revenue | FY2025 | 11% | New |
| Jan 31, 2025 | Net Cash Provided by Operating Activities | FY2025 | $950.00M – $1.03B | New |
| Jan 31, 2025 | Revenue Growth | FY2025 | +12% – +13% | New |
| Oct 25, 2024 | Adjusted EBITDA | FY2025 | $1.30B – $1.33B | Raised |
| Oct 25, 2024 | Adjusted Diluted EPS | FY2025 | $6.10 – $6.30 | Raised |
| Oct 25, 2024 | Free Cash Flow | FY2025 | $825.00M – $925.00M | Raised |
| Oct 25, 2024 | Adjusted EBITDA Margin on Revenue | FY2025 | 11% | Reaffirmed |
| Oct 25, 2024 | Net Cash Provided by Operating Activities | FY2025 | $925.00M – $1.03B | Raised |
| Oct 25, 2024 | Revenue Growth | FY2025 | +11% – +13% | New |
| Jul 26, 2024 | Adjusted EBITDA | FY2025 | $1.26B – $1.30B | Reaffirmed |
| Jul 26, 2024 | Adjusted Diluted EPS | FY2025 | $5.80 – $6.05 | Reaffirmed |
| Jul 26, 2024 | Free Cash Flow | FY2025 | $725.00M – $825.00M | New |
| Jul 26, 2024 | Adjusted EBITDA Margin on Revenue | FY2025 | 11% | Reaffirmed |
| Jul 26, 2024 | Net Cash Provided by Operating Activities | FY2025 | $825.00M – $925.00M | Reaffirmed |
| Jul 26, 2024 | Revenue Growth | FY2025 | +8% – +11% | Reaffirmed |
| May 24, 2024 | Adjusted EBITDA | FY2025 | $1.26B – $1.30B | New |
| May 24, 2024 | Adjusted Diluted EPS | FY2025 | $5.80 – $6.05 | New |
| May 24, 2024 | Adjusted EBITDA Margin on Revenue | FY2025 | 11% | New |
| May 24, 2024 | Net Cash Provided by Operating Activities | FY2025 | $825.00M – $925.00M | New |
| May 24, 2024 | Revenue Growth | FY2025 | +8% – +11% | New |
| Jan 26, 2024 | Adjusted EBITDA | FY2024 | $1.16B – $1.18B | Raised |
| Jan 26, 2024 | Adjusted Diluted EPS | FY2024 | $5.25 – $5.40 | Raised |
| Jan 26, 2024 | Adjusted EBITDA Margin on Revenue | FY2024 | 11% | Raised |
| Jan 26, 2024 | Net Cash Provided by Operating Activities | FY2024 | $200.00M – $275.00M | Raised |
| Jan 26, 2024 | Revenue Growth | FY2024 | +14% – +15% | Raised |
| Oct 27, 2023 | Adjusted EBITDA | FY2024 | $1.12B – $1.15B | Raised |
| Oct 27, 2023 | Adjusted Diluted EPS | FY2024 | $4.95 – $5.10 | Raised |
| Oct 27, 2023 | Net Cash Provided by Operating Activities | FY2024 | $160.00M – $260.00M | Reaffirmed |
| Oct 27, 2023 | Revenue Growth | FY2024 | +11% – +14% | New |
| Jul 28, 2023 | Adjusted EBITDA | FY2024 | $1.08B – $1.11B | Reaffirmed |
| Jul 28, 2023 | Adjusted Diluted EPS | FY2024 | $4.80 – $4.95 | Reaffirmed |
| Jul 28, 2023 | Adjusted EBITDA Margin on Revenue | FY2024 | 10% – 11% | New |
| Jul 28, 2023 | Updated Net Cash Provided by Operating Activities | FY2024 | $160.00M – $260.00M | Lowered |
| Jul 28, 2023 | Revenue Growth | FY2024 | +7% – +11% | Reaffirmed |
| May 26, 2023 | capital expenditures | FY2024 | $85.00M – $105.00M | New |
| May 26, 2023 | Adjusted EBITDA | FY2024 | $1.08B – $1.11B | New |
| May 26, 2023 | Adjusted Diluted EPS | FY2024 | $4.80 – $4.95 | New |
| May 26, 2023 | Net Cash Provided by Operating Activities | FY2024 | $500.00M – $600.00M | New |
| May 26, 2023 | Revenue Growth | FY2024 | +7% – +11% | New |
| Jan 27, 2023 | Adjusted EBITDA | FY2023 | $995.00M – $1.02B | Raised |
| Jan 27, 2023 | Adjusted Diluted EPS | FY2023 | $4.35 – $4.50 | Raised |
| Jan 27, 2023 | Net Cash Provided by Operating Activities | FY2023 | $875.00M – $950.00M | Reaffirmed |
| Jan 27, 2023 | Revenue Growth | FY2023 | +9.5% – +10.5% | Raised |
| Oct 28, 2022 | Adjusted EBITDA | FY2023 | $975.00M – $1.02B | Raised |
| Oct 28, 2022 | Adjusted Diluted EPS | FY2023 | $4.25 – $4.50 | Raised |
| Oct 28, 2022 | Net Cash Provided by Operating Activities | FY2023 | $875.00M – $950.00M | Raised |
| Oct 28, 2022 | Revenue Growth | FY2023 | +8% – +10% | Raised |
| Jul 29, 2022 | Adjusted EBITDA | FY2023 | $950.00M – $1.00B | Reaffirmed |
| Jul 29, 2022 | Adjusted Diluted EPS | FY2023 | $4.15 – $4.45 | Reaffirmed |
| Jul 29, 2022 | Net Cash Provided by Operating Activities | FY2023 | $850.00M – $950.00M | Raised |
| Jul 29, 2022 | Revenue Growth | FY2023 | +5% – +9% | New |
| May 20, 2022 | Adjusted EBITDA | FY2023 | $950.00M – $1.00B | New |
| May 20, 2022 | Adjusted Diluted EPS | FY2023 | $4.15 – $4.45 | New |
| May 20, 2022 | total Operating Cash Flow | FY2023 | $300.00M – $400.00M | New |
| May 20, 2022 | Net Cash Provided by Operating Activities | FY2023 | $850.00M – $950.00M | New |
| May 20, 2022 | Revenue Growth | FY2023 | +5% – +9% | New |
| Jan 28, 2022 | Adjusted EBITDA Margin on Revenue | FY2022 | 11% | New |
| Jan 28, 2022 | Adjusted Diluted EPS | FY2022 | $4.10 – $4.30 | Reaffirmed |
| Jan 28, 2022 | Net Cash Provided by Operating Activities | FY2022 | $700.00M – $750.00M | Lowered |
| Jan 28, 2022 | Revenue Growth | FY2022 | +5.7% – +7.2% | New |
| Oct 29, 2021 | Adjusted Diluted EPS | FY2022 | $4.10 – $4.30 | New |
| Oct 29, 2021 | Net Cash Provided by Operating Activities | FY2022 | $800.00M – $850.00M | New |
| Oct 29, 2021 | Revenue Growth | FY2022 | +7% – +10% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Booz Allen Hamilton filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Update
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results